AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
PDF (1.6 MB)
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Research Article | Open Access

MIF-173G > C Polymorphism and Susceptibility to Cutaneous Leishmaniasis in Iraq

Hasan Raheem Khudhur( )Ghada Basil Alomashi
Department of Microbiology, College of Medicine, University of Al-Qadisiyah, Iraq
Show Author Information

Abstract

Cutaneous leishmaniasis (CL) is a parasitic disease transmitted by biting of the sandfly; it is a severe health problem in many regions of the world. The disease is endemic in Iraq and other countries. In Iraq, there are two main species of the genus Leishmania causing the infection: L. tropica and L. major. Previous studies suggested that a genetic makeup of host also had an essential role in the outcome of the disease. The present study investigated the association between CL and functionally active polymorphisms in the macrophage migration inhibitory factor (MIF gene). Samples of peripheral blood were collected from 60 patients with CL and 32 apparently healthy controls. MIF-173G > C polymorphism was detected in patients and control groups by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) technique. There was no statistically significant difference in the MIF-173G > C polymorphism between the CL patients and the healthy controls (P = 0.234), as well as no association between MIF-173G > C polymorphisms and CL; the frequency of allele C showed a trend towards lower frequency in patients as compared to that observed in the control group (P = 0.512).

References

[1]

S. Ahmed, M. Colmenares, L. Soong, et al., Intradermal infection model for pathogenesis and vaccine studies of murine visceral leishmaniasis. Infection and Immunity, 2003. 71(1): 401-410.

[2]

J. Blum, P. Desjeux, E. Schwartz, et al., Treatment of cutaneous leishmaniasis among travellers. Journal of Antimicrobial Chemotherapy, 2004. 53(2): 158-166.

[3]

P. Tripathi, V. Singh, and S. Naik, Immune response to leishmania: paradox rather than paradigm. FEMS Immunology & Medical Microbiology, 2007. 51(2): 229-242.

[4]

P. Desjeux, Worldwide increasing risk factors for leishmaniasis. Medical Microbiology and Immunology, 2001. 190(1-2): 77-79.

[5]

J. Gonzalez, Baghdad boil festers as new enemy of GIs New York Daily, 2003: 112-117.

[6]

P. Renner, T. Roger, and T. Calandra, Macrophage migration inhibitory factor: gene polymorphisms and susceptibility to inflammatory diseases. Clinical Infectious Diseases, 2005. 41(Supplement 7): S513-S519.

[7]

R.A. Mitchell, H. Liao, J. Chesney, et al., Macrophage migration inhibitory factor (MIF) sustains macrophage proinflammatory function by inhibiting p53: Regulatory role in the innate immune response. Proceedings of the National Academy of Sciences, 2002. 99(1): 345-350.

[8]

P. Courville, R. Chaloupka, and M. Cellier, Recent progress in structure–function analyses of Nramp proton-dependent metal-ion transporters. Biochemistry and Cell Biology, 2006. 84(6): 960-978.

[9]

R. Donn, D. Ray, Macrophage migration inhibitory factor: molecular, cellular and genetic aspects of a key neuroendocrine molecule. Journal of Endocrinology, 2004, 182(1): 1-9.

[10]

S. Jüttner, J. Bernhagen, C.N. Metz, et al., Migration inhibitory factor induces killing of Leishmania major by macrophages: dependence on reactive nitrogen intermediates and endogenous TNF-α. The Journal of Immunology, 1998. 161(5): 2383-2390.

[11]

C.D.J.F. Covas, C.C. Cardoso, A. Gomes-Silva, et al., Candidate gene case-control and functional study shows macrophage inhibitory factor (MIF) polymorphism is associated with cutaneous leishmaniasis. Cytokine, 2013. 61(1): 168-172.

[12]

A.M. Da-Cruz, R. Bittar, M. Mattos, et al., T-cell-mediated immune responses in patients with cutaneous or mucosal leishmaniasis: long-term evaluation after therapy. Clinical and Diagnostic Laboratory Immunology, 2002. 9(2): 251-256.

[13]

R. Donn, E. Shelley, W. Ollier, et al., A novel 5'-flanking region polymorphism of macrophage migration inhibitory factor is associated with systemic‐onset juvenile idiopathic arthritis. Arthritis & Rheumatology, 2001. 44(8): 1782-1785.

[14]

R.C. Team, R Foundation for Statistical Computing; Vienna, Austria: 2014. R: A language and environment for statistical computing, 2015: 2013.

[15]

R. Makhija, A. Kingsnorth, and A. Demaine, Gene polymorphisms of the macrophage migration inhibitory factor and acute pancreatitis. Jop, 2007. 8(3): 289-295.

[16]

M.Z. Alam, A.M. Bhutto, F.R. Soomro, et al., Population genetics of Leishmania (Leishmania) major DNA isolated from cutaneous leishmaniasis patients in Pakistan based on multilocus microsatellite typing. Parasites & Vectors, 2014. 7(1): 332.

Nano Biomedicine and Engineering
Pages 213-216
Cite this article:
Raheem Khudhur H, Basil Alomashi G. MIF-173G > C Polymorphism and Susceptibility to Cutaneous Leishmaniasis in Iraq. Nano Biomedicine and Engineering, 2018, 10(3): 213-216. https://doi.org/10.5101/nbe.v10i3.p213-216

431

Views

23

Downloads

2

Crossref

2

Scopus

Altmetrics

Received: 16 April 2018
Accepted: 07 June 2018
Published: 16 July 2018
© Ghada Basil Alomashi, Hasan Raheem Khudhur.

This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Return